Chemotherapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chemotherapy stocks.

Chemotherapy Stocks Recent News

Date Stock Title
May 14 URGN UroGen Pharma First Quarter 2024 Earnings: Misses Expectations
May 13 URGN UroGen Pharma Ltd. (URGN) Q1 2024 Earnings Call Transcript
May 13 URGN UroGen Pharma Ltd (URGN) Q1 2024 Earnings: Misses EPS Estimates, Revenue Slightly Above Expectations
May 13 URGN UroGen Pharma GAAP EPS of -$0.97 misses by $0.08, revenue of $18.78M misses by $2.61M
May 13 URGN UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
May 12 URGN Shareholders in UroGen Pharma (NASDAQ:URGN) have lost 67%, as stock drops 11% this past week
May 11 CHRS Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 10 CHRS Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript
May 10 URGN UroGen Pharma Q1 2024 Earnings Preview
May 10 KPTI Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 10 GLYC GlycoMimetics GAAP EPS of -$0.17 in-line
May 10 CHRS Coherus BioSciences, Inc. (CHRS) Q1 2024 Earnings Call Transcript
May 9 CHRS Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
May 9 CHRS Coherus BioSciences Non-GAAP EPS of -$0.32 misses by $0.11, revenue of $77.1M misses by $6.65M
May 9 CHRS Coherus BioSciences Reports First Quarter 2024 Financial ResultsĀ and Provides Business Update
May 9 GLYC GlycoMimetics, Inc. (GLYC) Corporate Update Call Transcript
May 9 KPTI Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
May 9 MBRX Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
May 9 CHRS Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
May 9 INFU InfuSystem GAAP EPS of -$0.05 misses by $0.06, revenue of $32M beats by $0.45M
Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

Browse All Tags